| Home > Publications Database > Role of genetics in amyotrophic lateral sclerosis: a large cohort study in Chinese mainland population. > print |
| 001 | 164181 | ||
| 005 | 20240313115345.0 | ||
| 024 | 7 | _ | |a pmc:PMC9411893 |2 pmc |
| 024 | 7 | _ | |a 10.1136/jmedgenet-2021-107965 |2 doi |
| 024 | 7 | _ | |a pmid:34544842 |2 pmid |
| 024 | 7 | _ | |a 0022-2593 |2 ISSN |
| 024 | 7 | _ | |a 1468-6244 |2 ISSN |
| 024 | 7 | _ | |a altmetric:113813568 |2 altmetric |
| 037 | _ | _ | |a DZNE-2022-00837 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Chen, Yong-Ping |b 0 |
| 245 | _ | _ | |a Role of genetics in amyotrophic lateral sclerosis: a large cohort study in Chinese mainland population. |
| 260 | _ | _ | |a London |c 2022 |b BMJ Publishing Group |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1661506957_605 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a CC BY-NC: https://creativecommons.org/licenses/by-nc/4.0/ |
| 520 | _ | _ | |a A large number of new causative and risk genes for amyotrophic lateral sclerosis (ALS) have been identified mostly in patients of European ancestry. In contrast, we know relatively little regarding the genetics of ALS in other ethnic populations. This study aims to provide a comprehensive analysis of the genetics of ALS in an unprecedented large cohort of Chinese mainland population and correlate with the clinical features of rare variants carriers.A total of 1587 patients, including 64 familial ALS (FALS) and 1523 sporadic ALS (SALS), and 1866 in-house controls were analysed by whole-exome sequencing and/or testing for G4C2 repeats in C9orf72. Forty-one ALS-associated genes were analysed.155 patients, including 26 (40.6%) FALS and 129 (8.5%) SALS, carrying rare pathogenic/likely pathogenic (P/LP) variants of ALS causative genes were identified. SOD1 was the most common mutated gene, followed by C9orf72, FUS, NEK1, TARDBP and TBK1. By burden analysis, rare variants in SOD1, FUS and TARDBP contributed to the collective risk for ALS (p<2.5e-6) at the gene level, but at the allelic level TARDBP p.Gly294Val and FUS p.Arg521Cys and p.Arg521His were the most important single variants causing ALS. Clinically, P/LP variants in TARDBP and C9orf72 were associated with poor prognosis, in FUS linked with younger age of onset, and C9orf72 repeats tended to affect cognition.Our data provide essential information for understanding the genetic and clinical features of ALS in China and for optimal design of genetic testing and evaluation of disease prognosis. |
| 536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a genetic variation |2 Other |
| 650 | _ | 7 | |a genetics |2 Other |
| 650 | _ | 7 | |a medical |2 Other |
| 650 | _ | 7 | |a neurodegenerative diseases |2 Other |
| 650 | _ | 2 | |a Amyotrophic Lateral Sclerosis: epidemiology |2 MeSH |
| 650 | _ | 2 | |a Amyotrophic Lateral Sclerosis: genetics |2 MeSH |
| 650 | _ | 2 | |a C9orf72 Protein: genetics |2 MeSH |
| 650 | _ | 2 | |a Cohort Studies |2 MeSH |
| 650 | _ | 2 | |a Genetic Predisposition to Disease |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Mutation: genetics |2 MeSH |
| 650 | _ | 2 | |a Superoxide Dismutase-1: genetics |2 MeSH |
| 700 | 1 | _ | |a Yu, Shi-Hui |b 1 |
| 700 | 1 | _ | |a Wei, Qian-Qian |b 2 |
| 700 | 1 | _ | |a Cao, Bei |b 3 |
| 700 | 1 | _ | |a Gu, Xiao-Jing |b 4 |
| 700 | 1 | _ | |a Chen, Xue-Ping |b 5 |
| 700 | 1 | _ | |a Song, Wei |b 6 |
| 700 | 1 | _ | |a Zhao, Bi |b 7 |
| 700 | 1 | _ | |a Wu, Ying |b 8 |
| 700 | 1 | _ | |a Sun, Ming-Ming |b 9 |
| 700 | 1 | _ | |a Liu, Fei-Fei |b 10 |
| 700 | 1 | _ | |a Hou, Yan-Bing |b 11 |
| 700 | 1 | _ | |a Ou, Ru-Wei |b 12 |
| 700 | 1 | _ | |a Zhang, Ling-Yu |b 13 |
| 700 | 1 | _ | |a Liu, Kun-Cheng |b 14 |
| 700 | 1 | _ | |a Lin, Jun-Yu |b 15 |
| 700 | 1 | _ | |a Xu, Xin-Ran |b 16 |
| 700 | 1 | _ | |a Li, Chun-Yu |b 17 |
| 700 | 1 | _ | |a Yang, Jing |b 18 |
| 700 | 1 | _ | |a Jiang, Zheng |b 19 |
| 700 | 1 | _ | |a Liu, Jiao |b 20 |
| 700 | 1 | _ | |a Cheng, Yang-Fan |b 21 |
| 700 | 1 | _ | |a Xiao, Yi |b 22 |
| 700 | 1 | _ | |a Chen, Ke |b 23 |
| 700 | 1 | _ | |a Feng, Fei |b 24 |
| 700 | 1 | _ | |a Cai, Ying-Ying |b 25 |
| 700 | 1 | _ | |a Li, Shi-Rong |b 26 |
| 700 | 1 | _ | |a Hu, Tao |b 27 |
| 700 | 1 | _ | |a Yuan, Xiao-Qin |b 28 |
| 700 | 1 | _ | |a Guo, Xiao-Yan |b 29 |
| 700 | 1 | _ | |a Liu, Hui |0 P:(DE-2719)9001971 |b 30 |u dzne |
| 700 | 1 | _ | |a Han, Qing |b 31 |
| 700 | 1 | _ | |a Zhou, Qing-Qing |b 32 |
| 700 | 1 | _ | |a Shao, Na |b 33 |
| 700 | 1 | _ | |a Li, Jian-Peng |b 34 |
| 700 | 1 | _ | |a Pan, Ping-Lei |b 35 |
| 700 | 1 | _ | |a Ma, Sha |b 36 |
| 700 | 1 | _ | |a Shang, Hui-Fang |0 0000-0003-0947-1151 |b 37 |
| 773 | _ | _ | |a 10.1136/jmedgenet-2021-107965 |g p. jmedgenet-2021-107965 - |0 PERI:(DE-600)2009590-9 |n 9 |p 840-849 |t Journal of medical genetics |v 59 |y 2022 |x 0022-2593 |
| 856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/164181/files/DZNE-2022-00837.pdf |
| 856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/164181/files/DZNE-2022-00837.pdf?subformat=pdfa |
| 909 | C | O | |o oai:pub.dzne.de:164181 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 30 |6 P:(DE-2719)9001971 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
| 914 | 1 | _ | |y 2022 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-17 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-17 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-17 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-01-28 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J MED GENET : 2021 |d 2022-11-17 |
| 915 | _ | _ | |a Creative Commons Attribution-NonCommercial CC BY-NC 4.0 |0 LIC:(DE-HGF)CCBYNC4 |2 HGFVOC |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-01-28 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2022-11-17 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-17 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b J MED GENET : 2021 |d 2022-11-17 |
| 915 | _ | _ | |a National-Konsortium |0 StatID:(DE-HGF)0430 |2 StatID |d 2022-11-17 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-01-28 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2022-11-17 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-17 |
| 920 | 1 | _ | |0 I:(DE-2719)1210000 |k AG Gasser |l Parkinson Genetics |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-2719)1210000 |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|